Zobrazeno 1 - 10
of 27
pro vyhledávání: '"A M Starzer"'
Autor:
Maximilian J. Mair, Agnieszka Maj-Hes, Alina Nussbaumer-Pröll, Rainer Puhr, Agnieszka Christenheit, Marlene Troch, Hannah C. Puhr, Angelika M. Starzer, Ariane Steindl, Sabine Eberl, Helmuth Haslacher, Thomas Perkmann, Christoph Minichsdorfer, Gerald W. Prager, Wolfgang W. Lamm, Anna S. Berghoff, Barbara Kiesewetter, Markus Zeitlinger, Matthias Preusser, Markus Raderer
Publikováno v:
Infectious Agents and Cancer, Vol 18, Iss 1, Pp 1-10 (2023)
Abstract Background Patients with cancer are at high risk for severe courses of COVID-19. Based on (pre-)clinical data suggesting a potential protective effect due to the immunomodulating properties of azithromycin, we have initiated a prospective ra
Externí odkaz:
https://doaj.org/article/ea5d091cfe5e4460a474548a11cbcfca
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
The introduction of immune checkpoint inhibitors has changed the therapeutic possibilities for various cancer types. However, despite the success in some entities, a significant fraction of patients does not respond to immune checkpoint inhibitors. A
Externí odkaz:
https://doaj.org/article/493a286c7fba4339b351964705b3148d
Autor:
Matthias Preusser, Leonhard Müllauer, Anna S Berghoff, Sebastian Bauer, Gerwin Heller, Thomas Brodowicz, Wolfgang Lamm, Katharina Feldmann, Angelika M Starzer, Rainer Hamacher, Erwin Tomasich, Teresa Hatziioannou, Stefan Traint, Iris M Noebauer-Huhmann, Julia Furtner, Gabriele Amann, Hans-Ulrich Schildhaus
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Background Some sarcomas respond to immune checkpoint inhibition, but predictive biomarkers are unknown. We analyzed tumor DNA methylation profiles in relation to immunological parameters and response to anti-programmed cell death 1 (anti-PD-1) immun
Externí odkaz:
https://doaj.org/article/a79916ad1b1542e9b504874a3913dd32
Autor:
Anna S. Berghoff, Angelika M. Starzer
Publikováno v:
ESMO Open, Vol 4, Iss Suppl 3 (2019)
Externí odkaz:
https://doaj.org/article/326e675131f94256932b6806253cccfc
Autor:
Ariane Steindl, Tabea J. Brunner, Kira Heimbach, Katharina Schweighart, Georg M. Moser, Helena M. Niziolek, Elisabeth Moor, Judith Kreminger, Angelika M. Starzer, Karin Dieckmann, Brigitte Gatterbauer, Georg Widhalm, Matthias Preusser, Anna S. Berghoff
Publikováno v:
European Journal of Cancer. 162:170-181
An accurate classification of patients with brain metastases (BMs) is an important foundation to guide individualised treatment decisions and to formulate BM cohorts for modern clinical trials.Six thousand and thirty-one patients with newly diagnosed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bd34248e88054be0d091a3f19bfeecb
https://doi.org/10.1016/j.ejca.2021.12.005
https://doi.org/10.1016/j.ejca.2021.12.005
Autor:
Angelika M. Starzer, Ariane Steindl, Maximilian J. Mair, Carola Deischinger, Anika Simonovska, Georg Widhalm, Brigitte Gatterbauer, Karin Dieckmann, Gerwin Heller, Matthias Preusser, Anna S. Berghoff
Publikováno v:
Br J Cancer
Systemic inflammation measured by the neutrophil-to-lymphocyte ratio (NLR), leucocyte-to-lymphocyte ratio (LLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR) and CRP/albumin ratio (CRP/Alb) was shown to impact the survival p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83981a7dc2aee41470d1218b55a25b2d
https://europepmc.org/articles/PMC8927113/
https://europepmc.org/articles/PMC8927113/
Autor:
Thorsten Fuereder, Matthias Preusser, G. Ortmayr, Dominic Fong, Manfred Mitterer, Helmuth Haslacher, Julia M. Berger, Wolfgang Lamm, Selma Tobudic, Hannah Christina Puhr, Ariane Steindl, Markus Raderer, Thomas Perkmann, Maximilian J. Mair, Robert Strassl, Angelika M. Starzer, Anna S. Berghoff
Publikováno v:
JAMA Oncol
Importance: To our knowledge, little is known about antibody development after SARS-CoV-2 vaccination in immunocompromised individuals, such as patients with cancer. Objective: To determine whether hematooncological patients develop anti-SARS-CoV-2 a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8b59e1869e4475ec43b39aeb5345ece
https://pubmed.ncbi.nlm.nih.gov/34591965
https://pubmed.ncbi.nlm.nih.gov/34591965
Autor:
A S Berghoff, R Bartsch, J Furtner, M Marhold, E S Bergen, S Roider-Schur, A M Starzer, H Forstner, B Rottenmanner, K Dieckmann, Z Bago-Horvath, G Widhalm, A Ilhan-Mutlu, C Minichsdorfer, T Fuereder, C F Singer, A Weltermann, H Haslacher, T Szekeres, R Puhr, M Preusser
Publikováno v:
Neuro-Oncology. 24:ii10-ii10
Background T-DXd is a novel antibody-drug conjugate with high activity in HER2-positive metastatic breast cancer. The prospective, single-arm, single-centre phase II TUXEDO-1 trial showed clinically relevant activity of T-DXd in HER2-positive BC pts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b4210e7bde8f8dc90f7d94943322ec2
https://doi.org/10.1093/neuonc/noac174.030
https://doi.org/10.1093/neuonc/noac174.030
Autor:
A M Starzer, M Kleinberger, K Feldmann, E Tomasich, T Hatziioannou, C Paiato, G Heller, J Kreminger, S Traint, A Steindl, J M Ressler, G Widhalm, B Gatterbauer, K Dieckmann, L Müllauer, M Preusser, A S Berghoff
Publikováno v:
Neuro-Oncology. 24:ii12-ii12
Background Immunotherapy (IO) has changed the treatment landscape of metastatic cancer patients, however, treatment resistance is frequent. We aimed to characterize the inflammatory tumor microenvironment in brain metastases (BM) after IO to gain a d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d11d79af059f6343ab25f6921e46dd9
https://doi.org/10.1093/neuonc/noac174.037
https://doi.org/10.1093/neuonc/noac174.037
Autor:
Stefan Traint, Sebastian Bauer, Thomas Brodowicz, Gerwin Heller, Katharina Feldmann, Julia Furtner, Gabriele Amann, Rainer Hamacher, Teresa Hatziioannou, Iris M. Noebauer-Huhmann, Leonhard Müllauer, Wolfgang Lamm, Angelika M. Starzer, Erwin Tomasich, Hans-Ulrich Schildhaus, Anna S. Berghoff, Matthias Preusser
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundSome sarcomas respond to immune checkpoint inhibition, but predictive biomarkers are unknown. We analyzed tumor DNA methylation profiles in relation to immunological parameters and response to anti-programmed cell death 1 (anti-PD-1) immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::757e63d071fac70057305b1163d6f22a
https://jitc.bmj.com/content/9/3/e001458.full
https://jitc.bmj.com/content/9/3/e001458.full